(Total Views: 630)
Posted On: 12/23/2020 1:31:43 PM
Post# of 72445
Warp Speed bets $356M to mass manufacture a Merck drug for severe Covid-19
MK-7110, by contrast, was shown to reduce the risk of respiratory failure or death by 50% in a trial of 203 late-stage patients, OncoImmune announced in September. It also appeared to give patients 60% odds of improving.
https://endpts.com/warp-speed-bets-356m-to-ma...-covid-19/
MK-7110, by contrast, was shown to reduce the risk of respiratory failure or death by 50% in a trial of 203 late-stage patients, OncoImmune announced in September. It also appeared to give patients 60% odds of improving.
https://endpts.com/warp-speed-bets-356m-to-ma...-covid-19/
(0)
(0)
